--- title: "ACHV.US (ACHV.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ACHV.US/news.md" symbol: "ACHV.US" name: "ACHV.US" parent: "https://longbridge.com/en/quote/ACHV.US.md" datetime: "2026-05-20T01:46:21.515Z" locales: - [en](https://longbridge.com/en/quote/ACHV.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ACHV.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ACHV.US/news.md) --- # ACHV.US (ACHV.US) — Related News ### [Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News](https://longbridge.com/en/news/286952863.md) *2026-05-19T10:15:28.000Z* > Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment | ACHV Stock News ### [Achieve Life Sciences Reaffirmed at Buy as Financing, Leadership Refresh, and Strong Cytisinicline Data Support Unchanged $10 Price Target](https://longbridge.com/en/news/286303279.md) *2026-05-13T18:35:23.000Z* > Maxim Group analyst Jason McCarthy reaffirmed a Buy rating on Achieve Life Sciences with a $10 price target, citing the ### [Lake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)](https://longbridge.com/en/news/286269618.md) *2026-05-13T13:20:57.000Z* > Lake Street analyst Mark Smith has reaffirmed a Buy rating for Achieve Life Sciences (ACHV) with a price target of $11.0 ### [Achieve Life Sciences (ACHV) Gets a Buy from H.C. Wainwright](https://longbridge.com/en/news/286134451.md) *2026-05-12T16:35:22.000Z* > H.C. Wainwright analyst Brandon Folkes has reiterated a Buy rating on Achieve Life Sciences (ACHV) with a price target o ### [Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript](https://longbridge.com/en/news/286108844.md) *2026-05-12T13:16:07.000Z* > Achieve Life Sciences (NASDAQ:ACHV) reported its Q1 2026 results, highlighting a $180 million capital raise and potentia ### [Achieve Life Sciences Adds Director Amid Board Transitions](https://longbridge.com/en/news/286099106.md) *2026-05-12T12:16:41.000Z* > Achieve Life Sciences has appointed Christopher Martin to its board as part of ongoing transitions, with a $40,000 retai ### [Achieve Life Sciences | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286089003.md) *2026-05-12T11:23:42.000Z*